Produse pentru comerțul cu produse chimice 70 (2)

Ester etilic de acid trifluoroacetic - 383-63-1; TFAEt, ETFA; Utilizat în Celecoxib, Efavirenz, Lisinopril, Sitagliptin

Ester etilic de acid trifluoroacetic - 383-63-1; TFAEt, ETFA; Utilizat în Celecoxib, Efavirenz, Lisinopril, Sitagliptin

Trifluoressigsäureethylester gehört zur Gruppe der Essigsäurederivate. Das Zwischenprodukt wird in der Agro-, Elektronik-, Feinchemikalien-, Parfümerie-, Pharma- und Veterinärindustrie verwendet sowie bei der Herstellung von Celecoxib, Efavirenz, Lisinopril & Sitagliptinphosphat. Name:Tri­fluoro­essig­säure­ethyl­ester Synonym:TFAEt Synonym 2:ETFA CAS Nummer:383-63-1 API Anwendung:Celecoxib, Efavirenz, Lisinopril API Anwendung 2:Sitagliptin phosphat
Ketoprofen - Ketoprofen; Ingredient Farmaceutic Activ; EP; JP; CAS 22071-15-4

Ketoprofen - Ketoprofen; Ingredient Farmaceutic Activ; EP; JP; CAS 22071-15-4

Ketoprofen is a synthetically synthesized Active Pharmaceutical Ingredient, produced under cGMP, compliant with EP, JP monographs. Its CAS-N° reads 22071-15-4. It is used in treatment of arthritis-related inflammatory pains, severe toothaches that result in the inflammation of the gums or nerve pain. Ketoprofen is an acidic, non-opioid analgesic used for pain and inflammation. By inhibiting prostaglandin synthesis at the key enzyme cyclooxygenase, it can be used for acute and chronic pain (e.g. arthrosis and arthritides). Like most active ingredients in its class, it is poorly tolerated by the gastrointestinal tract, a particular side effect is light sensitization. Detailed specification, Certificate of Analysis and samples are available on request. CAS:22071-15-4 Product Information:API Route of Synthesis:Synthetic Patent Expiry:EU, US - expired Indication:Analgesic, Anti-inflammatory Dosage:Oral Name:Ketoprofen